nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Hyperacusis—Temozolomide—malignant glioma	0.0327	0.0514	CcSEcCtD
Flumazenil—Paranoia—Carmustine—malignant glioma	0.0185	0.0291	CcSEcCtD
Flumazenil—GABRA6—brainstem—malignant glioma	0.017	0.0527	CbGeAlD
Flumazenil—Stupor—Carmustine—malignant glioma	0.0169	0.0265	CcSEcCtD
Flumazenil—Scotoma—Carmustine—malignant glioma	0.0166	0.0261	CcSEcCtD
Flumazenil—Scotoma—Temozolomide—malignant glioma	0.0161	0.0252	CcSEcCtD
Flumazenil—Injection site pain—Carmustine—malignant glioma	0.0155	0.0243	CcSEcCtD
Flumazenil—GABRA6—telencephalon—malignant glioma	0.0151	0.0467	CbGeAlD
Flumazenil—Rigors—Temozolomide—malignant glioma	0.0149	0.0234	CcSEcCtD
Flumazenil—Speech disorder—Carmustine—malignant glioma	0.0147	0.023	CcSEcCtD
Flumazenil—GABRA5—telencephalon—malignant glioma	0.0147	0.0453	CbGeAlD
Flumazenil—Speech disorder—Temozolomide—malignant glioma	0.0142	0.0222	CcSEcCtD
Flumazenil—GABRA4—telencephalon—malignant glioma	0.0133	0.0411	CbGeAlD
Flumazenil—Hearing impaired—Temozolomide—malignant glioma	0.0128	0.0201	CcSEcCtD
Flumazenil—Injection site reaction—Carmustine—malignant glioma	0.0125	0.0197	CcSEcCtD
Flumazenil—Depressed level of consciousness—Carmustine—malignant glioma	0.0122	0.0191	CcSEcCtD
Flumazenil—Depressed level of consciousness—Temozolomide—malignant glioma	0.0118	0.0185	CcSEcCtD
Flumazenil—GABRA2—brainstem—malignant glioma	0.0115	0.0354	CbGeAlD
Flumazenil—GABRG2—telencephalon—malignant glioma	0.0111	0.0344	CbGeAlD
Flumazenil—GABRA1—brainstem—malignant glioma	0.0111	0.0342	CbGeAlD
Flumazenil—Abnormal vision—Carmustine—malignant glioma	0.011	0.0173	CcSEcCtD
Flumazenil—Abnormal vision—Temozolomide—malignant glioma	0.0106	0.0167	CcSEcCtD
Flumazenil—Thrombophlebitis—Carmustine—malignant glioma	0.0106	0.0166	CcSEcCtD
Flumazenil—Thrombophlebitis—Temozolomide—malignant glioma	0.0102	0.016	CcSEcCtD
Flumazenil—GABRA2—telencephalon—malignant glioma	0.0102	0.0314	CbGeAlD
Flumazenil—Deafness—Temozolomide—malignant glioma	0.0099	0.0155	CcSEcCtD
Flumazenil—GABRA1—telencephalon—malignant glioma	0.00983	0.0304	CbGeAlD
Flumazenil—Nasal congestion—Temozolomide—malignant glioma	0.00972	0.0152	CcSEcCtD
Flumazenil—Hot flush—Temozolomide—malignant glioma	0.00947	0.0148	CcSEcCtD
Flumazenil—Menopausal symptoms—Temozolomide—malignant glioma	0.00939	0.0147	CcSEcCtD
Flumazenil—Diplopia—Carmustine—malignant glioma	0.00916	0.0144	CcSEcCtD
Flumazenil—Diplopia—Temozolomide—malignant glioma	0.00886	0.0139	CcSEcCtD
Flumazenil—GABRG2—medulla oblongata—malignant glioma	0.00875	0.027	CbGeAlD
Flumazenil—Affect lability—Temozolomide—malignant glioma	0.00872	0.0137	CcSEcCtD
Flumazenil—Ataxia—Carmustine—malignant glioma	0.00862	0.0135	CcSEcCtD
Flumazenil—GABRA6—central nervous system—malignant glioma	0.0086	0.0266	CbGeAlD
Flumazenil—GABRB3—telencephalon—malignant glioma	0.00855	0.0264	CbGeAlD
Flumazenil—GABRA6—cerebellum—malignant glioma	0.0084	0.026	CbGeAlD
Flumazenil—Mood swings—Temozolomide—malignant glioma	0.00839	0.0132	CcSEcCtD
Flumazenil—GABRA5—central nervous system—malignant glioma	0.00834	0.0258	CbGeAlD
Flumazenil—Ataxia—Temozolomide—malignant glioma	0.00833	0.0131	CcSEcCtD
Flumazenil—GABRG2—midbrain—malignant glioma	0.008	0.0247	CbGeAlD
Flumazenil—GABRG2—spinal cord—malignant glioma	0.0078	0.0241	CbGeAlD
Flumazenil—GABRA3—central nervous system—malignant glioma	0.00777	0.024	CbGeAlD
Flumazenil—GABRA1—medulla oblongata—malignant glioma	0.00773	0.0239	CbGeAlD
Flumazenil—GABRA4—central nervous system—malignant glioma	0.00757	0.0234	CbGeAlD
Flumazenil—Sweating increased—Temozolomide—malignant glioma	0.00746	0.0117	CcSEcCtD
Flumazenil—GABRA4—cerebellum—malignant glioma	0.0074	0.0228	CbGeAlD
Flumazenil—GABRA1—midbrain—malignant glioma	0.00706	0.0218	CbGeAlD
Flumazenil—GABRA1—spinal cord—malignant glioma	0.00689	0.0213	CbGeAlD
Flumazenil—GABRA6—brain—malignant glioma	0.00683	0.0211	CbGeAlD
Flumazenil—GABRB3—medulla oblongata—malignant glioma	0.00672	0.0208	CbGeAlD
Flumazenil—GABRA5—brain—malignant glioma	0.00662	0.0205	CbGeAlD
Flumazenil—GABRG2—central nervous system—malignant glioma	0.00633	0.0196	CbGeAlD
Flumazenil—Hypoaesthesia—Carmustine—malignant glioma	0.00631	0.00989	CcSEcCtD
Flumazenil—Hallucination—Carmustine—malignant glioma	0.00631	0.00989	CcSEcCtD
Flumazenil—GABRG2—cerebellum—malignant glioma	0.00619	0.0191	CbGeAlD
Flumazenil—GABRA3—brain—malignant glioma	0.00616	0.019	CbGeAlD
Flumazenil—GABRB3—midbrain—malignant glioma	0.00614	0.019	CbGeAlD
Flumazenil—Visual impairment—Carmustine—malignant glioma	0.00611	0.00958	CcSEcCtD
Flumazenil—Hallucination—Temozolomide—malignant glioma	0.0061	0.00956	CcSEcCtD
Flumazenil—Hypoaesthesia—Temozolomide—malignant glioma	0.0061	0.00956	CcSEcCtD
Flumazenil—GABRA4—brain—malignant glioma	0.00601	0.0186	CbGeAlD
Flumazenil—GABRB3—spinal cord—malignant glioma	0.00599	0.0185	CbGeAlD
Flumazenil—Visual impairment—Temozolomide—malignant glioma	0.0059	0.00926	CcSEcCtD
Flumazenil—Flushing—Carmustine—malignant glioma	0.00588	0.00923	CcSEcCtD
Flumazenil—GABRA2—central nervous system—malignant glioma	0.00578	0.0179	CbGeAlD
Flumazenil—Tinnitus—Temozolomide—malignant glioma	0.00571	0.00896	CcSEcCtD
Flumazenil—Flushing—Temozolomide—malignant glioma	0.00569	0.00892	CcSEcCtD
Flumazenil—Arrhythmia—Carmustine—malignant glioma	0.00566	0.00888	CcSEcCtD
Flumazenil—GABRA2—cerebellum—malignant glioma	0.00565	0.0175	CbGeAlD
Flumazenil—GABRA1—central nervous system—malignant glioma	0.00559	0.0173	CbGeAlD
Flumazenil—Erythema—Carmustine—malignant glioma	0.00552	0.00866	CcSEcCtD
Flumazenil—Chills—Temozolomide—malignant glioma	0.0055	0.00862	CcSEcCtD
Flumazenil—GABRA1—cerebellum—malignant glioma	0.00546	0.0169	CbGeAlD
Flumazenil—Erythema—Temozolomide—malignant glioma	0.00533	0.00837	CcSEcCtD
Flumazenil—Vision blurred—Carmustine—malignant glioma	0.0052	0.00816	CcSEcCtD
Flumazenil—Tremor—Carmustine—malignant glioma	0.00517	0.00811	CcSEcCtD
Flumazenil—Agitation—Carmustine—malignant glioma	0.00507	0.00796	CcSEcCtD
Flumazenil—Vision blurred—Temozolomide—malignant glioma	0.00503	0.00788	CcSEcCtD
Flumazenil—GABRG2—brain—malignant glioma	0.00503	0.0155	CbGeAlD
Flumazenil—Tremor—Temozolomide—malignant glioma	0.005	0.00784	CcSEcCtD
Flumazenil—Ill-defined disorder—Temozolomide—malignant glioma	0.00495	0.00776	CcSEcCtD
Flumazenil—Agitation—Temozolomide—malignant glioma	0.0049	0.00769	CcSEcCtD
Flumazenil—GABRB3—central nervous system—malignant glioma	0.00486	0.015	CbGeAlD
Flumazenil—Malaise—Temozolomide—malignant glioma	0.00481	0.00754	CcSEcCtD
Flumazenil—Vertigo—Temozolomide—malignant glioma	0.00479	0.00752	CcSEcCtD
Flumazenil—Hypertension—Carmustine—malignant glioma	0.00476	0.00747	CcSEcCtD
Flumazenil—GABRB3—cerebellum—malignant glioma	0.00475	0.0147	CbGeAlD
Flumazenil—Palpitations—Temozolomide—malignant glioma	0.00471	0.00739	CcSEcCtD
Flumazenil—Chest pain—Carmustine—malignant glioma	0.0047	0.00737	CcSEcCtD
Flumazenil—Anxiety—Carmustine—malignant glioma	0.00468	0.00734	CcSEcCtD
Flumazenil—Cough—Temozolomide—malignant glioma	0.00465	0.0073	CcSEcCtD
Flumazenil—Hypertension—Temozolomide—malignant glioma	0.0046	0.00722	CcSEcCtD
Flumazenil—GABRA2—brain—malignant glioma	0.00459	0.0142	CbGeAlD
Flumazenil—Confusional state—Carmustine—malignant glioma	0.00454	0.00712	CcSEcCtD
Flumazenil—Anxiety—Temozolomide—malignant glioma	0.00452	0.0071	CcSEcCtD
Flumazenil—Discomfort—Temozolomide—malignant glioma	0.00449	0.00704	CcSEcCtD
Flumazenil—Dry mouth—Temozolomide—malignant glioma	0.00444	0.00697	CcSEcCtD
Flumazenil—GABRA1—brain—malignant glioma	0.00444	0.0137	CbGeAlD
Flumazenil—Tachycardia—Carmustine—malignant glioma	0.0044	0.0069	CcSEcCtD
Flumazenil—Confusional state—Temozolomide—malignant glioma	0.00439	0.00688	CcSEcCtD
Flumazenil—Hypotension—Carmustine—malignant glioma	0.00421	0.0066	CcSEcCtD
Flumazenil—Hyperhidrosis—Temozolomide—malignant glioma	0.00421	0.0066	CcSEcCtD
Flumazenil—Insomnia—Carmustine—malignant glioma	0.00407	0.00639	CcSEcCtD
Flumazenil—Paraesthesia—Carmustine—malignant glioma	0.00404	0.00634	CcSEcCtD
Flumazenil—Dyspnoea—Carmustine—malignant glioma	0.00402	0.0063	CcSEcCtD
Flumazenil—Somnolence—Carmustine—malignant glioma	0.004	0.00628	CcSEcCtD
Flumazenil—Insomnia—Temozolomide—malignant glioma	0.00394	0.00618	CcSEcCtD
Flumazenil—Paraesthesia—Temozolomide—malignant glioma	0.00391	0.00613	CcSEcCtD
Flumazenil—Dyspnoea—Temozolomide—malignant glioma	0.00388	0.00609	CcSEcCtD
Flumazenil—Somnolence—Temozolomide—malignant glioma	0.00387	0.00607	CcSEcCtD
Flumazenil—GABRB3—brain—malignant glioma	0.00386	0.0119	CbGeAlD
Flumazenil—Pain—Carmustine—malignant glioma	0.00385	0.00604	CcSEcCtD
Flumazenil—Fatigue—Temozolomide—malignant glioma	0.00375	0.00589	CcSEcCtD
Flumazenil—Pain—Temozolomide—malignant glioma	0.00372	0.00584	CcSEcCtD
Flumazenil—Feeling abnormal—Carmustine—malignant glioma	0.00371	0.00582	CcSEcCtD
Flumazenil—Feeling abnormal—Temozolomide—malignant glioma	0.00359	0.00563	CcSEcCtD
Flumazenil—Urticaria—Temozolomide—malignant glioma	0.00346	0.00542	CcSEcCtD
Flumazenil—Hypersensitivity—Carmustine—malignant glioma	0.00332	0.00521	CcSEcCtD
Flumazenil—Asthenia—Carmustine—malignant glioma	0.00323	0.00507	CcSEcCtD
Flumazenil—Hypersensitivity—Temozolomide—malignant glioma	0.00321	0.00503	CcSEcCtD
Flumazenil—Asthenia—Temozolomide—malignant glioma	0.00312	0.0049	CcSEcCtD
Flumazenil—Pruritus—Temozolomide—malignant glioma	0.00308	0.00483	CcSEcCtD
Flumazenil—Dizziness—Carmustine—malignant glioma	0.00298	0.00467	CcSEcCtD
Flumazenil—Dizziness—Temozolomide—malignant glioma	0.00288	0.00451	CcSEcCtD
Flumazenil—Vomiting—Carmustine—malignant glioma	0.00286	0.00449	CcSEcCtD
Flumazenil—Rash—Carmustine—malignant glioma	0.00284	0.00445	CcSEcCtD
Flumazenil—Dermatitis—Carmustine—malignant glioma	0.00284	0.00445	CcSEcCtD
Flumazenil—Headache—Carmustine—malignant glioma	0.00282	0.00443	CcSEcCtD
Flumazenil—Vomiting—Temozolomide—malignant glioma	0.00277	0.00434	CcSEcCtD
Flumazenil—Rash—Temozolomide—malignant glioma	0.00274	0.0043	CcSEcCtD
Flumazenil—Dermatitis—Temozolomide—malignant glioma	0.00274	0.0043	CcSEcCtD
Flumazenil—Headache—Temozolomide—malignant glioma	0.00273	0.00428	CcSEcCtD
Flumazenil—Nausea—Carmustine—malignant glioma	0.00268	0.0042	CcSEcCtD
Flumazenil—Nausea—Temozolomide—malignant glioma	0.00259	0.00406	CcSEcCtD
Flumazenil—GABRA6—Orphan transporters—COX8A—malignant glioma	0.000954	0.0246	CbGpPWpGaD
Flumazenil—GABRA4—Orphan transporters—COX8A—malignant glioma	0.000942	0.0243	CbGpPWpGaD
Flumazenil—GABRA5—Orphan transporters—COX8A—malignant glioma	0.000837	0.0216	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—COX8A—malignant glioma	0.000822	0.0212	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—COX8A—malignant glioma	0.000807	0.0208	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—COX8A—malignant glioma	0.000802	0.0207	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—COX8A—malignant glioma	0.000788	0.0203	CbGpPWpGaD
Flumazenil—GABRA6—Orphan transporters—APOD—malignant glioma	0.000742	0.0191	CbGpPWpGaD
Flumazenil—GABRA4—Orphan transporters—APOD—malignant glioma	0.000732	0.0189	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—COX8A—malignant glioma	0.000689	0.0178	CbGpPWpGaD
Flumazenil—GABRA5—Orphan transporters—APOD—malignant glioma	0.000651	0.0168	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—APOD—malignant glioma	0.000639	0.0165	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—APOD—malignant glioma	0.000628	0.0162	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—APOD—malignant glioma	0.000624	0.0161	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—APOD—malignant glioma	0.000613	0.0158	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—APOD—malignant glioma	0.000535	0.0138	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—ATP1B2—malignant glioma	0.000535	0.0138	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—ATP1B2—malignant glioma	0.000528	0.0136	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—NTRK3—malignant glioma	0.000526	0.0136	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—ATP1B2—malignant glioma	0.000469	0.0121	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—ATP1B2—malignant glioma	0.000461	0.0119	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—ATP1B2—malignant glioma	0.000453	0.0117	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—ATP1B2—malignant glioma	0.00045	0.0116	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—ATP1B2—malignant glioma	0.000442	0.0114	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—ATP1B2—malignant glioma	0.000386	0.00996	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000273	0.00703	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000252	0.00649	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000243	0.00627	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—NTRK2—malignant glioma	0.000235	0.00605	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000233	0.006	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00023	0.00593	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000213	0.00549	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00021	0.00542	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000209	0.00539	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000207	0.00533	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000204	0.00527	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000201	0.00517	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000197	0.00508	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000197	0.00507	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000196	0.00505	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000194	0.00501	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000192	0.00496	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—NTRK1—malignant glioma	0.000191	0.00494	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000189	0.00487	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000189	0.00487	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000187	0.00482	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000186	0.0048	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000184	0.00474	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000184	0.00473	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000183	0.00473	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000181	0.00467	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00018	0.00465	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00018	0.00465	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000179	0.00462	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000179	0.00461	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000177	0.00457	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000176	0.00454	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000176	0.00454	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000173	0.00446	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000173	0.00445	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000169	0.00437	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000168	0.00433	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000167	0.00429	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000165	0.00427	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000163	0.00421	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000162	0.00419	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00016	0.00413	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BCHE—malignant glioma	0.00016	0.00413	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—APOD—malignant glioma	0.000159	0.0041	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—BCHE—malignant glioma	0.000158	0.00408	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000158	0.00406	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000157	0.00404	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000156	0.00402	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SPP1—malignant glioma	0.000156	0.00401	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000155	0.00401	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000154	0.00396	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000154	0.00396	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000153	0.00395	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000152	0.00393	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000151	0.00389	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—SLC6A3—malignant glioma	0.000151	0.00389	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00015	0.00386	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—SLC6A3—malignant glioma	0.000149	0.00384	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000142	0.00366	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000142	0.00366	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BCHE—malignant glioma	0.000141	0.00363	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00014	0.00362	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BCHE—malignant glioma	0.000138	0.00356	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BCHE—malignant glioma	0.000136	0.0035	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000135	0.00349	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BCHE—malignant glioma	0.000135	0.00348	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000134	0.00347	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BCHE—malignant glioma	0.000132	0.00341	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—SLC6A3—malignant glioma	0.000132	0.00341	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000131	0.00337	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—SLC6A3—malignant glioma	0.00013	0.00335	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—BAD—malignant glioma	0.000128	0.00331	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—SLC6A3—malignant glioma	0.000128	0.00329	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—SLC6A3—malignant glioma	0.000127	0.00327	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000125	0.00321	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—SLC6A3—malignant glioma	0.000124	0.00321	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—APC—malignant glioma	0.000124	0.0032	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000122	0.00315	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—PTPN11—malignant glioma	0.000122	0.00315	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.00012	0.0031	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000119	0.00308	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000119	0.00307	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000119	0.00306	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000117	0.00303	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000117	0.00302	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000117	0.00302	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BCHE—malignant glioma	0.000116	0.00298	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000114	0.00293	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000109	0.00281	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000107	0.00275	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RAF1—malignant glioma	0.000106	0.00272	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000105	0.00272	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000104	0.00269	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RAF1—malignant glioma	0.000104	0.00269	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000104	0.00268	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000103	0.00264	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000103	0.00264	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000102	0.00263	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000101	0.0026	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.0001	0.00259	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.0001	0.00258	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	9.97e-05	0.00257	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	9.83e-05	0.00253	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	9.79e-05	0.00253	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	9.75e-05	0.00251	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	9.37e-05	0.00241	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TFRC—malignant glioma	9.27e-05	0.00239	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RAF1—malignant glioma	9.26e-05	0.00239	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	9.2e-05	0.00237	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TFRC—malignant glioma	9.15e-05	0.00236	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RAF1—malignant glioma	9.09e-05	0.00234	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	9.04e-05	0.00233	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	8.98e-05	0.00232	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—MDM2—malignant glioma	8.95e-05	0.00231	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RAF1—malignant glioma	8.93e-05	0.0023	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—RAF1—malignant glioma	8.91e-05	0.0023	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RAF1—malignant glioma	8.87e-05	0.00229	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—MDM2—malignant glioma	8.83e-05	0.00228	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	8.82e-05	0.00227	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—RAF1—malignant glioma	8.8e-05	0.00227	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	8.76e-05	0.00226	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RAF1—malignant glioma	8.71e-05	0.00225	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	8.59e-05	0.00221	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	8.56e-05	0.00221	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.51e-05	0.00219	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.41e-05	0.00217	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BRAF—malignant glioma	8.18e-05	0.00211	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	8.13e-05	0.0021	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.1e-05	0.00209	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—BRAF—malignant glioma	8.08e-05	0.00208	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8e-05	0.00206	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	7.99e-05	0.00206	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	7.85e-05	0.00202	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	7.85e-05	0.00202	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	7.82e-05	0.00202	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	7.8e-05	0.00201	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	7.71e-05	0.00199	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	7.71e-05	0.00199	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	7.68e-05	0.00198	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	7.66e-05	0.00197	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RAF1—malignant glioma	7.62e-05	0.00196	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	7.57e-05	0.00195	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	7.55e-05	0.00195	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	7.52e-05	0.00194	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	7.5e-05	0.00193	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.47e-05	0.00193	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	7.39e-05	0.0019	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	7.37e-05	0.0019	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	7.36e-05	0.0019	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	7.36e-05	0.0019	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.33e-05	0.00189	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.21e-05	0.00186	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BRAF—malignant glioma	7.18e-05	0.00185	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.16e-05	0.00185	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.11e-05	0.00183	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	7.07e-05	0.00182	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	7.05e-05	0.00182	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BRAF—malignant glioma	7.05e-05	0.00182	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.03e-05	0.00181	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.98e-05	0.0018	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BRAF—malignant glioma	6.93e-05	0.00179	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BRAF—malignant glioma	6.88e-05	0.00177	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.86e-05	0.00177	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—MDM2—malignant glioma	6.85e-05	0.00177	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—RAF1—malignant glioma	6.83e-05	0.00176	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.82e-05	0.00176	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—MDM2—malignant glioma	6.77e-05	0.00174	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BRAF—malignant glioma	6.76e-05	0.00174	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—RAF1—malignant glioma	6.74e-05	0.00174	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.69e-05	0.00173	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.69e-05	0.00173	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	6.46e-05	0.00167	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	6.44e-05	0.00166	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.15e-05	0.00158	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—MDM2—malignant glioma	6.01e-05	0.00155	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—RAF1—malignant glioma	5.99e-05	0.00154	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	5.98e-05	0.00154	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BRAF—malignant glioma	5.91e-05	0.00152	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—MDM2—malignant glioma	5.9e-05	0.00152	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—RAF1—malignant glioma	5.88e-05	0.00152	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.85e-05	0.00151	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—MDM2—malignant glioma	5.8e-05	0.0015	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—RAF1—malignant glioma	5.78e-05	0.00149	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—MDM2—malignant glioma	5.76e-05	0.00149	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—RAF1—malignant glioma	5.74e-05	0.00148	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—MDM2—malignant glioma	5.66e-05	0.00146	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—RAF1—malignant glioma	5.64e-05	0.00145	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	5.13e-05	0.00132	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—MDM2—malignant glioma	4.95e-05	0.00128	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—RAF1—malignant glioma	4.93e-05	0.00127	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	4.74e-05	0.00122	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	3.67e-05	0.000947	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	3.63e-05	0.000935	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	3.22e-05	0.000831	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	3.16e-05	0.000816	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.11e-05	0.000802	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	3.09e-05	0.000796	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.03e-05	0.000782	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.65e-05	0.000684	CbGpPWpGaD
